Click here to learn more or to register for the International Symposium on Malignant Mesothelioma.
[youtube=http://www.youtube.com/watch?v=AeaZWg50vKg]
Vivace Therapeutics Receives FDA Orphan Drug Designation for VT3989 for Mesothelioma Treatment
Vivace Therapeutics, a company that develops cancer treatments, announced on July 30, 2025, that the U.S. Food and Drug Administration (FDA) has granted its experimental
